Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation

Overview of attention for article published in Molecular Neurodegeneration, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog

twitter: 8 X users
facebook: 1 Facebook page

Citations

dimensions_citation: 116 Dimensions

Readers on

mendeley: 97 Mendeley
citeulike: 1 CiteULike

Summary News Blogs X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Labome News, 13 Aug 2018

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.